Scroll

Burcon Announces Appointment of Calvin Chi Leung Ng to its Board of Directors 07/23/2019

Vancouver, British Columbia, July 23, 2019 — Burcon NutraScience Corporation (TSX: BU), a global leader in developing functionally and nutritionally valuable plant-proteins, is pleased to announce the appointment of Mr. Calvin Chi Leung Ng as a director of its board. 

Mr. Ng is a director of Large Scale Investments Limited (“Large Scale”) and Great Intelligence Limited (“Great Intelligence”), two companies that together own in the aggregate, approximately 26% of the common shares of Burcon.  Large Scale and Great Intelligence are wholly-owned subsidiaries of Firewood Elite Limited, a company wholly-owned by Mr. Alan Chan, a director of Burcon.  Mr. Ng is also Group Legal Counsel for ITC Properties Group Limited, a real estate property development and investment company.  Mr. Ng has over 20 years’ experience of advising on and executing corporate and commercial transactions in law firm and private sectors.  Mr. Ng holds a Bachelor’s degree in Laws and Postgraduate Certificate in Laws from The University of Hong Kong. 

Dr. Lorne Tyrrell, Chairman of Burcon’s board of directors said, “I am pleased to have Calvin join our board of directors.   His extensive legal experience and knowledge in commercial transactions will be an asset to Burcon in the future.”

 

About Burcon NutraScience Corporation

Burcon is a leader in developing functionally and nutritionally valuable plant proteins.  The company has developed an extensive portfolio of composition, application, and process patents originating from a core protein extraction and purification technology.  Burcon’s family of plant proteins includes Peazazz®,  a uniquely soluble and clean-tasting pea protein, Puratein®, Supertein® and Nutratein® canola proteins with exceptional functionality and valuable nutritional profiles, and Nutratein-PS and Nutratein-TZ, Burcon’s new pea and canola protein blends that have exceptional functional characteristics, low allergenicity, and a nutritional value exceeding those of standard pea proteins in the market today.  Burcon’s CLARISOY® soy protein — under license to the Archer Daniels Midland Company — offers clarity and high-quality protein nutrition for low-pH beverage systems, and excellent solubility and exceptionally clean flavour at any pH. For more information about the company, visit www.burcon.ca.

 

The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward- looking statements or forward-looking information can be identified by words such as “anticipate,” “intend,” “plan,” “goal,” “project,” “estimate,” “expect,” “believe”, “future,” “likely,” “may,” “should,” “could”, “will” and similar references to future periods. All statements other than statements of historical fact included in this release are forward-looking statements, including, without limitation, statements regarding expectations, intentions and plans contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon’s plans and expectations include the actual results of business negotiations, marketing activities, adverse general economic, market or business conditions, regulatory changes and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled “Risk Factors” in Burcon’s annual information form dated June 28, 2019 filed with the Canadian securities administrators on www.sedar.com.  Any forward-looking statement or information only speaks as of the date on which it was made and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and accordingly, investors should not rely on such statements.

CLARISOY is a trademark of Archer Daniels Midland Company.

 

Investor Contact:

Paul Lam

Manager, Business Development

Burcon NutraScience Corporation

Tel (604) 733-0896, Toll-free (888) 408-7960

plam@burcon.ca  www.burcon.ca

 

Media Contact:

Steve Campbell, APR

President

Campbell & Company Public Relations

Tel (604) 888-5267

TECH@CCOM-PR.COM